CTI-118

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameCTI-118
Drug Alias NameCTI-118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus internalization inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoston University Medical CampusUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesBoston University Medical CampusUniversity Of California San Diego
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A